Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Portugal

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancer|June 15, 2011
Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiationKevin S Choe, Daniel J Haraf, Abhishek Solanki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancerFred R Rosen, Daniel J Haraf, Merrill S Kies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancerEverett E Vokes, Kerstin Stenson, Fred R Rosen, et al.
British Journal of Cancer|August 9, 2022
Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinomaAri J Rosenberg, Nishant Agrawal, Alexander T Pearson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2014
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomasTanguy Y Seiwert, Zhixiang Zuo, Michaela K Keck, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancer|June 15, 2011
Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiationKevin S Choe, Daniel J Haraf, Abhishek Solanki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancerFred R Rosen, Daniel J Haraf, Merrill S Kies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancerEverett E Vokes, Kerstin Stenson, Fred R Rosen, et al.
British Journal of Cancer|August 9, 2022
Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinomaAri J Rosenberg, Nishant Agrawal, Alexander T Pearson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2014
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomasTanguy Y Seiwert, Zhixiang Zuo, Michaela K Keck, et al.
Pageof 2